Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amriya Pharmaceutical Industries is a prominent Egyptian pharmaceutical manufacturer and a key subsidiary of the Pharco Pharmaceuticals group. Established in 1989 and headquartered in Alexandria, the company operates one of the largest manufacturing complexes in the Middle East and North Africa region. Amriya specializes in the production of a diverse range of generic medicines across therapeutic areas such as cardiology, gastroenterology, neurology, and infectious diseases. The company gained significant international recognition for its role in producing affordable, high-quality treatments for Hepatitis C, supporting large-scale public health initiatives in Egypt. Adhering to international GMP standards, Amriya exports its products to numerous markets across Africa, Europe, and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amriya Pharmaceutical Industries.